Edosuyi O, Adesuyi A, Choi M, Igbe I, Oyekan A
Eur J Pharmacol. 2022; 938:175441.
PMID: 36463945
PMC: 9772084.
DOI: 10.1016/j.ejphar.2022.175441.
Thongsepee N, Martviset P, Chantree P, Sornchuer P, Sangpairoj K, Prathaphan P
Heliyon. 2022; 8(10):e10972.
PMID: 36247159
PMC: 9563186.
DOI: 10.1016/j.heliyon.2022.e10972.
Satou R, Franco M, Dugas C, Katsurada A, Navar L
Int J Mol Sci. 2022; 23(14).
PMID: 35887028
PMC: 9319385.
DOI: 10.3390/ijms23147680.
Bautista-Perez R, Perez-Mendez O, Cano-Martinez A, Pacheco U, Santamaria J, Rodriguez-Iturbe F
Int J Mol Sci. 2020; 21(11).
PMID: 32516946
PMC: 7312644.
DOI: 10.3390/ijms21114041.
Garcia-Arroyo F, Tapia E, Blas-Marron M, Gonzaga G, Silverio O, Cristobal M
Int J Biol Sci. 2017; 13(8):961-975.
PMID: 28924378
PMC: 5599902.
DOI: 10.7150/ijbs.20074.
Role of GLUT4 on angiotensin 2-induced systemic and renal hemodynamics.
Igbe I, Omogbai E, Oyekan A
J Exp Pharmacol. 2016; 5:1-13.
PMID: 27186132
PMC: 4863536.
DOI: 10.2147/JEP.S34583.
Physiology Lab Demonstration: Glomerular Filtration Rate in a Rat.
Hinojosa-Laborde C, Jespersen B, Shade R
J Vis Exp. 2015; (101):e52425.
PMID: 26274567
PMC: 4545064.
DOI: 10.3791/52425.
M-atrial natriuretic peptide and nitroglycerin in a canine model of experimental acute hypertensive heart failure: differential actions of 2 cGMP activating therapeutics.
McKie P, Cataliotti A, Ichiki T, Sangaralingham S, Chen H, Burnett Jr J
J Am Heart Assoc. 2014; 3(1):e000206.
PMID: 24385449
PMC: 3959692.
DOI: 10.1161/JAHA.113.000206.
The effect of aliskiren on urinary cytokine/chemokine responses to clamped hyperglycaemia in type 1 diabetes.
Cherney D, Reich H, Scholey J, Daneman D, Mahmud F, Har R
Diabetologia. 2013; 56(10):2308-17.
PMID: 23893332
DOI: 10.1007/s00125-013-3000-3.
Renal hyperfiltration and systemic blood pressure in patients with uncomplicated type 1 diabetes mellitus.
Yang G, Maahs D, Perkins B, Cherney D
PLoS One. 2013; 8(7):e68908.
PMID: 23861950
PMC: 3701674.
DOI: 10.1371/journal.pone.0068908.
The effect of renal hyperfiltration on urinary inflammatory cytokines/chemokines in patients with uncomplicated type 1 diabetes mellitus.
Har R, Scholey J, Daneman D, Mahmud F, Dekker R, Lai V
Diabetologia. 2013; 56(5):1166-73.
PMID: 23412605
DOI: 10.1007/s00125-013-2857-5.
Impaired pressure natriuresis resulting in salt-sensitive hypertension is caused by tubulointerstitial immune cell infiltration in the kidney.
Franco M, Tapia E, Bautista R, Pacheco U, Santamaria J, Quiroz Y
Am J Physiol Renal Physiol. 2013; 304(7):F982-90.
PMID: 23364804
PMC: 3625854.
DOI: 10.1152/ajprenal.00463.2012.
Synergistic effect of uricase blockade plus physiological amounts of fructose-glucose on glomerular hypertension and oxidative stress in rats.
Tapia E, Cristobal M, Garcia-Arroyo F, Soto V, Monroy-Sanchez F, Pacheco U
Am J Physiol Renal Physiol. 2013; 304(6):F727-36.
PMID: 23303409
PMC: 3602695.
DOI: 10.1152/ajprenal.00485.2012.
Sex differences in renal responses to hyperglycemia, L-arginine, and L-NMMA in humans with uncomplicated type 1 diabetes.
Cherney D, Scholey J, Sochett E
Diabetes Care. 2012; 36(5):1290-6.
PMID: 23250800
PMC: 3631825.
DOI: 10.2337/dc12-1305.
Antenatal betamethasone exposure alters renal responses to angiotensin-(1-7) in uninephrectomized adult male sheep.
Bi J, Contag S, Carey L, Tang L, Valego N, Chappell M
J Renin Angiotensin Aldosterone Syst. 2012; 14(4):290-8.
PMID: 23161144
PMC: 4020597.
DOI: 10.1177/1470320312465217.
Curcumin induces Nrf2 nuclear translocation and prevents glomerular hypertension, hyperfiltration, oxidant stress, and the decrease in antioxidant enzymes in 5/6 nephrectomized rats.
Tapia E, Soto V, Ortiz-Vega K, Zarco-Marquez G, Molina-Jijon E, Cristobal-Garcia M
Oxid Med Cell Longev. 2012; 2012:269039.
PMID: 22919438
PMC: 3424005.
DOI: 10.1155/2012/269039.
Hyperfiltration and effect of nitric oxide inhibition on renal and endothelial function in humans with uncomplicated type 1 diabetes mellitus.
Cherney D, Reich H, Jiang S, Har R, Nasrallah R, Hebert R
Am J Physiol Regul Integr Comp Physiol. 2012; 303(7):R710-8.
PMID: 22855276
PMC: 3469667.
DOI: 10.1152/ajpregu.00286.2012.
Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging.
Sangaralingham S, Heublein D, Grande J, Cataliotti A, Rule A, McKie P
Am J Physiol Renal Physiol. 2011; 301(5):F943-52.
PMID: 21865266
PMC: 3213903.
DOI: 10.1152/ajprenal.00170.2011.
Contribution of renal purinergic receptors to renal vasoconstriction in angiotensin II-induced hypertensive rats.
Franco M, Bautista R, Tapia E, Soto V, Santamaria J, Osorio H
Am J Physiol Renal Physiol. 2011; 300(6):F1301-9.
PMID: 21367914
PMC: 3119140.
DOI: 10.1152/ajprenal.00367.2010.
A novel atrial natriuretic peptide based therapeutic in experimental angiotensin II mediated acute hypertension.
McKie P, Cataliotti A, Boerrigter G, Chen H, Sangaralingham S, Martin F
Hypertension. 2010; 56(6):1152-9.
PMID: 20975033
PMC: 4447201.
DOI: 10.1161/HYPERTENSIONAHA.110.159210.
